Block copolymer-based gadolinium nanoparticles as MRI contrast agents with high T 1 relaxivity

Nanomedicine

Volumn 7, Issue 2, 2012, Pages 211-218

  Hou, Sijian ^a   Tong, Sheng ^a   Zhou, Jun ^a   Bao, Gang ^a  

^a Emory University   (United States)

Author keywords

atom transfer radical polymerizations; gadolinium; MRI contrast agent; nanoparticles; T 1 relaxivity

Indexed keywords

COPOLYMER; GADOLINIUM CHELATE; GADOLINIUM NANOPARTICLE; GADOLINIUM PENTETATE; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; POLY(ETHYLENE GLYCOL)METHYL ETHER ACRYLATE B POLY[MONOTRITYLHYDROXY DI(ETHYLENE GLYCOL)ACRYLATE] B POLYETHYLENE GLYCOL B POLY[MONOTRITYLHYDROXY DI(ETHYLENE GLYCOL)ACRYLATE] B POLY(ETHYLENE GLYCOL)METHYL ETHER ACRYLATE COPOLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ATOM TRANSFER RADICAL POLYMERIZATION; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; DRUG STRUCTURE; MOUSE; NANOFABRICATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANIMALS; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MICE; NANOPARTICLES; POLYMERS; WHOLE BODY IMAGING;

EID: 84863131829     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.110     Document Type: Article

References (28)

1. Rovira A, Leon A. MR in the diagnosis and monitoring of multiple sclerosis: An overview. Eur. J. Radiol. 67, 409-414 (2008).
2. Lorusso V, Pascolo L, Fernetti C, Anelli PL, Uggeri F, Tiribelli C. Magnetic resonance contrast agents: from the bench to the patient. Curr. Pharm. Des. 11, 4079-4098 (2005).
3. Bellin MF. MR contrast agents, the old and the new. Eur. J. Radiol. 60, 314-323 (2006).
4. Delikatny EJ, Poptani H. MR techniques for in vivo molecular and cellular imaging. Radiol. Clin. N. Am. 43, 205-220 (2005).
5. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem. Soc. Rev. 35, 512-523 (2006).
6. Sirlin CB, Vera DR, Corbeil JA, Caballero MB, Buxton RB, Mattrey RF. Gadolinium-DTPA-dextran: A macromolecular MR blood pool contrast agent. Acad. Radiol. 11, 1361-1369 (2004).
7. Ye FR, Jeong EK, Jia ZJ, Yang TX, Parker D, Lu ZR. A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI. Bioconjug. Chem. 19, 2300-2303 (2008).
8. Bull SR, Guler MO, Bras RE, Meade TJ, Stupp SI. Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents. Nano Lett. 5, 1-4 (2005).
9. Langereis S, Dirksen A, Hackeng TM, van Genderen MHP, Meijer EW. Dendrimers and magnetic resonance imaging. N. J. Chem. 31, 1152-1160 (2007).
10. Cheng ZL, Thorek DLJ, Tsourkas A. Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted t 1 magnetic resonance imaging contrast agent. Angew. Chem. Int. Ed. Engl. 49, 346-350 (2010).
11. Mohs AM, Wang XH, Goodrich KC, Zong YD, Parker DL, Lu ZR. PEG-g-poly(GdDTPA-co-l-cystine): A biodegradable macromolecular blood pool contrast agent for MR imaging. Bioconjug. Chem. 15, 1424-1430 (2004).
12. Ladd DL, Hollister R, Peng X, et al. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties. Bioconjug. Chem. 10, 361-370 (1999).
13. Duarte MG, Gil MH, Peters JA, et al. Synthesis, characterization, and relaxivity of two linear Gd(DTPA)-polymer conjugates. Bioconjug. Chem. 12, 170-177 (2001).
14. Ghaghada K, Hawley C, Kawaji K, Annapragada A, Mukundan S. T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents -effect of liposome size and internal gadolinium concentration. Acad. Radiol. 15, 1259-1263 (2008).
15. Ayyagari AL, Zhang XD, Ghaghada KB, Annapragada A, Hu XP, Bellamkonda RV. Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn. Reson. Med. 55, 1023-1029 (2006).
16. Frias JC, Williams KJ, Fisher EA, Fayad ZA. Recombinant HDL-like nanoparticles: A specific contrast agent for MRI of atherosclerotic plaques. J. Am. Chem. Soc. 126, 16316-16317 (2004).
17. Turner JL, Pan DPJ, Plummer R, Chen ZY, Whittaker AK, Wooley KL. Synthesis of gadolinium-labeled shell-crosslinked nanoparticles for magnetic resonance imaging applications. Adv. Funct. Mat. 15, 1248-1254 (2005).
18. Reynolds CH, Annan N, Beshah K, et al. Gadolinium-loaded nanoparticles: new contrast agents for magnetic resonance imaging. J. Am. Chem. Soc. 122, 8940-8945 (2000).
19. Rieter WJ, Kim JS, Taylor KML, et al. Hybrid silica nanoparticles for multimodal imaging. Angew. Chem. Int. Ed. Engl. 46, 3680-3682 (2007).
20. Moriggi L, Cannizzo C, Dumas E, Mayer CR, Ulianov A, Helm L. Gold nanoparticles functionalized with gadolinium chelates as high-relaxivity MRI contrast agents. J. Am. Chem. Soc. 131, 10828-10829 (2009).
21. Nicolle GM, Toth E, Schmitt-Willich H, Raduchel B, Merbach AE. The impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agent. Chemistry 8, 1040-1048 (2002).
22. Matyjaszewski K, Xia JH. Atom transfer radical polymerization. Chem. Rev. 101, 2921-2990 (2001).
23. Ramakrishnan A, Dhamodharan R. Facile synthesis of ABC and CBABC multiblock copolymers of styrene, tert-butyl acrylate, and methyl methacrylate via room temperature ATRP of MMA. Macromolecules 36, 1039-1046 (2003).
24. Fukukawa KI, Rossin R, Hagooly A, et al. Synthesis and characterization of core-shell star copolymers for in vivo PET imaging applications. Biomacromolecules 9, 1329-1339 (2008).
25. Inoue Y, Matsugi T, Kashiwa N, Matyjaszewski K. Graft copolymers from linear polyethylene via atom transfer radical polymerization. Macromolecules 37, 3651-3658 (2004).
26. Pedreira WR, Queiroz CAD, Abrao A, Pimentel MM. Quantification of trace amounts of rare earth elements in high purity gadolinium oxide by sector field inductively coupled plasma mass spectrometry (ICP-MS). J. Alloys Compounds 374, 129-132 (2004).
27. Bottrill M, Nicholas LK, Long NJ. Lanthanides in magnetic resonance imaging. Chem. Soc. Rev. 35, 557-571 (2006).
28. Kobayashi H, Brechbiel MW. Nano-sized MRI contrast agents with dendrimer cores. Adv. Drug Deliv. Rev. 57, 2271-2286 (2005).